Literature DB >> 32410045

A Novel Mechanism of Specialized Proresolving Lipid Mediators Mitigating Radicular Pain: The Negative Interaction with NLRP3 Inflammasome.

Yi-Hao Wang1,2, Yan Li3, Jun-Nan Wang1, Qing-Xiang Zhao1, Shuang Wen1, Si-Cong Wang1, Tao Sun4.   

Abstract

Inhibition of immune and inflammatory reaction induced by the expose of nucleus pulposus (NP) could effectively ameliorate neuropathic pain in the lumbar disc herniation. Maresin1 (MaR1), as a macrophage-derived mediator of inflammation resolution, displayed potent anti-inflammatory action. In the present study, we attempted to elucidate the impact of MaR1 on radicular pain and the interaction with NLRP3 inflammasome. We established a rat model of non-compressive lumbar disc herniation and different administration (MaR1 or Caspase-1 inhibitor) was given to them. The paw withdrawal latency (PWL) and paw withdrawal thresholds (PWTs) were observed to assess pain behaviors. The spinal cord horns were collected and the levels of IL-1β and IL-18 were measured by ELISA. The mRNA and protein expression levels of NLRP3 inflammasome components were tested by RT-PCR, western blot and immunohistochemistry. The endogenous MaR1 levels of the spinal cord were analyzed using LC-MS/MS. The application of NP in the models lead to mechanical and thermal hypersensitivity, increased IL-1β and IL-18 levels and expressions of NLRP3 inflammasome components, which were reversed markedly by administration of MaR1. Caspase-1 inhibition also improved mechanical hypersensitivity, decreased the expressions of inflammatory cytokines and restrained the activation of inflammasome. Meanwhile, Caspase-1 inhibitor promoted the endogenous MaR1 synthesis, which was hindered in the pain models. Altogether, our study indicated that the negative interaction between MaR1 and NLRP3 inflammasome mediated the inflammatory response in spinal dorsal horn, which involved in the pathogenesis of radicular pain.

Entities:  

Keywords:  Caspase-1 inhibitor; Endogenous biosynthesis; Maresin 1 (MaR1); NLRP3 inflammasome; Radicular pain

Mesh:

Substances:

Year:  2020        PMID: 32410045     DOI: 10.1007/s11064-020-03050-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  6 in total

Review 1.  Specialized pro-resolving mediator network: an update on production and actions.

Authors:  Nan Chiang; Charles N Serhan
Journal:  Essays Biochem       Date:  2020-09-23       Impact factor: 8.000

2.  The Role of NF-κB/NLRP3 Inflammasome Signaling Pathway in Attenuating Pyroptosis by Melatonin Upon Spinal Nerve Ligation Models.

Authors:  Yi-Hao Wang; Xiao Gao; Yu-Ru Tang; Yang Yu; Ming-Jie Sun; Fu-Qiang Chen; Yan Li
Journal:  Neurochem Res       Date:  2021-09-13       Impact factor: 3.996

3.  Resolvin D1 ameliorates Inflammation-Mediated Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in rats by Modulating A20 and NLRP3 Inflammasome.

Authors:  Chengcong Wei; Shenquan Guo; Wenchao Liu; Fa Jin; Boyang Wei; Haiyan Fan; Hengxian Su; Jiahui Liu; Nan Zhang; Dazhao Fang; Guangxu Li; Shixing Shu; Xifeng Li; Xuying He; Xin Zhang; Chuanzhi Duan
Journal:  Front Pharmacol       Date:  2021-02-03       Impact factor: 5.810

Review 4.  Maresin-1 and Inflammatory Disease.

Authors:  Natsuko Saito-Sasaki; Yu Sawada; Motonobu Nakamura
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

5.  Receptor-Interacting Protein Kinase 3 Inhibition Relieves Mechanical Allodynia and Suppresses NLRP3 Inflammasome and NF-κB in a Rat Model of Spinal Cord Injury.

Authors:  Song Xue; Zhen-Xin Cao; Jun-Nan Wang; Qing-Xiang Zhao; Jie Han; Wen-Jie Yang; Tao Sun
Journal:  Front Mol Neurosci       Date:  2022-04-19       Impact factor: 5.639

6.  CTHRC1 promotes growth, migration and invasion of trophoblasts via reciprocal Wnt/β-catenin regulation.

Authors:  Yan Li; Bao-Xiang Xing; Yi-Hao Wang; Sha Yu; Han Zhao; Qing-Qing Lv; Cai-Xia Lu
Journal:  J Cell Commun Signal       Date:  2021-05-27       Impact factor: 5.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.